The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those ...

CereCura was co-founded by renowned scientist and UBC professor Pieter Cullis, who developed LNPs, the drug delivery system ...

Switching from etravirine- to doravirine-containing regimen maintains viral suppression in people with HIV-1 infection, including those with archived resistance to NNRTIs.

Jefferies London Healthcare Conference 2025 November 18, 2025 12:00 PM ESTCompany ParticipantsMatthew Gline - CEO ...

Grim revelations have surfaced from within the Department of Health and Human Services (HHS), exposing a culture of censorship surrounding critical discussions about the COVID-19 vaccine and its ...

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.

Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...

Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.

People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.

His institute’s covid contrarians seek to limit the government’s role in protecting Americans from disease. The Austin, Texas ...